Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Clinical trial NCT01561391 · COMPLETED

Trial details

NCT number: NCT01561391
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A With Inhibitors Haemophilia B With Inhibitors

Start date: 1998-04-01
Primary completion: 2004-05-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.